(S)-2-((3S,8aR)-3-(4-aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(1H)-yl)-4-phenylbutanoicacid;(?S,3S,8aR)-3-(4-Aminobutyl)hexahydro-1,4-dioxo-?-(2-phenylethyl)pyrrolo[1,2-a]pyrazine-2(1H)-acetic Acid; Lisinopril EP Impurity D;(2S)-2-[(3S,8aR)-3-(4-Aminobutyl)-1,4-dioxohexahydropyrrolo[1,2-a]pyrazin-2(H)-yl]-4-phenylbutanoic Acid;Lisinopril (S,S,R)-Diketopiperazine (~90%); ((R, S, S)-Diketopiperazine)
Lisinopril EP Impurity D is a fully characterized chemical compound used as a reference standard of API Lisinopril. The standard offered is compliant with regulatory guidelines. Lisinopril EP Impurity D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 219677-82-4
Related products
N-(1-Carboxy-3-phenylpropyl)-S-lisinopril Trisodium Salt (Mixture of diastereomers)
M.F.
M.W. 633.67
CAT# AR-L06104
CAS# NA
Lisinopril Impurity H (Dimer Impurity, Mixture of Diastereomers)
M.F.
M.W. 695.86
CAT# AR-L01752
CAS# NA
